Discover Tenders by Steel Bridge Sections Sector

Find the most relevant tenders for Steel Bridge Sections. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Steel Bridge Sections tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Steel Bridge Sections tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olanzapine Excl Dafo For The Production Of A Depot Isu Atc N05Ah03 Obo For The Period 01 08 24 31 07 26

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373800

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Naloxegol Atc A06Ah03 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373588

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bimatoprost Timolol Exclusively Edo Atc S01Ed62 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373231

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Open House Drug Rebate Agreements Ustekinumab Atc L04Ac05

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373143

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6371060

EMD:Ref Document

Bid Value: Ref Document

233 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ustekinumab Atc L04Ac05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369929

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegvisomant Atc H01Ax01 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369748

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Fesoterodine Atc G04Bd11 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369364

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Medicines Containing The Active Substance Guselkumab Atc L04Ac16

Deadline: 31 May 2026

Germany

Ref. No.: 6368757

EMD:Ref Document

Bid Value: Ref Document

233 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lisdexamfetamine Atc N06Ba12 Obg For The Period 01 08 24 31 07 25 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6367992

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Open House Biologics Discount Agreements 2024 08 Darbepoetin Alfa

Deadline: 01 Aug 2026

Germany

Ref. No.: 6352753

EMD:Ref Document

Bid Value: Ref Document

295 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 6345486

EMD:Ref Document

Bid Value: Ref Document

610 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab Atc R03Dx05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6344888

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Colistin Atc J01Xb01 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6340118

EMD:Ref Document

Bid Value: Ref Document

238 Days Left

Medicines Containing The Active Substance Ustekinumab Atc L04Ac05

Deadline: 31 May 2026

Germany

Ref. No.: 6337480

EMD:Ref Document

Bid Value: Ref Document

233 Days Left

Showing 36901 to 36915 of 37392 results

‹
1
2
...
2458
2459
2460
2461
2462
2463
2464
...
2492
2493
›

Discover Tenders by Steel Bridge Sections Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Steel Bridge Sections Sector

Filter Your Search

FREE Trial plan for all new users!